Leishmaniasis in humans: drug or vaccine therapy?

M Ghorbani, R Farhoudi - Drug design, development and therapy, 2017 - Taylor & Francis
Leishmania is an obligate intracellular pathogen that invades phagocytic host cells.
Approximately 30 different species of Phlebotomine sand flies can transmit this parasite …

New world and old world Leishmania infections: a practical review

I Kevric, MA Cappel, JH Keeling - Dermatologic clinics, 2015 - derm.theclinics.com
Leishmaniasis is a tropical disease caused by an intracellular parasite of the genus
Leishmania. The vector of transmission is the sandfly, which deposits one of the 20 disease …

Diagnosis and treatment of leishmaniasis: clinical practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical …

N Aronson, BL Herwaldt, M Libman… - Clinical infectious …, 2016 - academic.oup.com
It is important to realize that leishmaniasis guidelines cannot always account for individual
variation among patients. They are not intended to supplant physician judgment with respect …

Cutaneous leishmaniasis

R Reithinger, JC Dujardin, H Louzir… - The Lancet infectious …, 2007 - thelancet.com
Cutaneous leishmaniasis is endemic in the tropics and neotropics. It is often referred to as a
group of diseases because of the varied spectrum of clinical manifestations, which range …

Advances in leishmaniasis

HW Murray, JD Berman, CR Davies, NG Saravia - The Lancet, 2005 - thelancet.com
Governed by parasite and host factors and immunoinflammatory responses, the clinical
spectrum of leishmaniasis encompasses subclinical (inapparent), localised (skin lesions) …

Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis

H Goto, JAL Lindoso - Expert review of anti-infective therapy, 2010 - Taylor & Francis
Tegumentary leishmaniasis, comprising the cutaneous and mucocutaneous forms, is
caused by at least 13 dermotropic species of protozoa of the genus Leishmania, most of …

[HTML][HTML] Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World

LF Oliveira, AO Schubach, MM Martins, SL Passos… - Acta tropica, 2011 - Elsevier
Pentavalent antimonials are first-line drugs for the treatment of the cutaneous form of
American tegumentary leishmaniasis. Second-line drugs include amphotericin B and …

Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years

JD Berman - Clinical infectious diseases, 1997 - academic.oup.com
The current interest in leishmaniasis stems from the importance of this disease with respect
to travel medicine, veterans of Operation Desert Storm, humanitarian concerns, and infection …

Cutaneous and mucocutaneous leishmaniasis: Differential diagnosis, diagnosis, histopathology, and management

MZ Handler, PA Patel, R Kapila, Y Al-Qubati… - Journal of the American …, 2015 - Elsevier
The diagnosis of leishmaniasis can be challenging because it mimics both infectious and
malignant conditions. A misdiagnosis may lead to an unfavorable outcome. Using culture …

Miltefosine for new world cutaneous leishmaniasis

J Soto, BA Arana, J Toledo, N Rizzo… - Clinical infectious …, 2004 - academic.oup.com
The oral agent miltefosine has demonstrated a> 95% cure rate in Indian visceral
leishmaniasis. We performed a large, placebo-controlled study of miltefosine therapy (2.5 …